Related references
Note: Only part of the references are listed.Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda
Aline Uwimana et al.
NATURE MEDICINE (2020)
Artemisinin Resistance-Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015
Costanza Tacoli et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Drivers of improved health sector performance in Rwanda: a qualitative view from within
Felix Sayinzoga et al.
BMC HEALTH SERVICES RESEARCH (2016)
Susceptibility of Anopheles gambiae to insecticides used for malaria vector control in Rwanda
Emmanuel Hakizimana et al.
MALARIA JOURNAL (2016)
Trends and social differentials in child mortality in Rwanda 1990-2010: results from three demographic and health surveys
Aimable Musafili et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2015)
Rwanda 20 years on: investing in life
Agnes Binagwaho et al.
LANCET (2014)
Monitoring long-lasting insecticidal net (LLIN) durability to validate net serviceable life assumptions, in Rwanda
Emmanuel Hakizimana et al.
MALARIA JOURNAL (2014)
Nationwide implementation of integrated community case management of childhood illness in Rwanda
Catherine Mugeni et al.
GLOBAL HEALTH-SCIENCE AND PRACTICE (2014)
Trends in malaria cases, hospital admissions and deaths following scale-up of anti-malarial interventions, 2000-2010, Rwanda
Corine Karema et al.
MALARIA JOURNAL (2012)
Impact of health systems strengthening on coverage of maternal health services in Rwanda, 2000-2010: a systematic review
Maurice Bucagu et al.
REPRODUCTIVE HEALTH MATTERS (2012)
Molecular Correlates of High-Level Antifolate Resistance in Rwandan Children with Plasmodium falciparum Malaria
Corine Karema et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic precis
Marianne E. Sinka et al.
PARASITES & VECTORS (2010)
'Paying for performance' in Rwanda: does it pay off?
Andreas Kalk et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2010)
Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment
Mac Otten et al.
MALARIA JOURNAL (2009)
From malaria control to eradication: The WHO perspective
Kamini Mendis et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2009)
Innovations in Rwanda's health system: looking to the future
Dorothy E. Logie et al.
LANCET (2008)
Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural Rwanda
Amy C. Sievers et al.
MALARIA JOURNAL (2008)
High Risk of Severe Anaemia after Chlorproguanil-Dapsone plus Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency
Caterina I. Fanello et al.
PLOS ONE (2008)
Thresholds for health insurance in Rwanda: who should pay how much?
Jean-Olivier Schmidt et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults
CI Fanello et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria
CE Rwagacondo et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate
CE Rwagacondo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2003)
Unstable malaria transmission and maternal mortality - experiences from Rwanda
A Hammerich et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2002)
Share Paper
